Funded startups/LUREX BIO, INC
LB

LUREX BIO, INC

SEC filing
Biotechnology · Fort Lauderdale, FL
Form D on EDGAR
Amount raised$150Ksold at filing
Total offeringNot stated
Investors in the raise3count reported to the SEC
FiledAug 31, 2026first sale Jan 22, 2026

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Mark ShumateExecutive Officer, Director
George SensExecutive Officer
James ClarkPromoter
Horace Lanier, IIIExecutive Officer, Director

Executive officers, directors and promoters as listed on the Form D.

Filing history

FormFiledAmount soldOffering
D/AAug 31, 2026$150KIndefiniteEDGAR
DFeb 5, 2026$50KIndefiniteEDGAR